BANGKOK: The chair of Thailand's Thonburi Healthcare Group (THG) said on Wednesday (Aug 4) that a deal to import 20 million doses of the ...
People receive doses of the AstraZeneca COVID-19 vaccine at the Central Vaccination Center inside Bang Sue Grand Station in Bangkok on Jun 21, 2021. BANGKOK: The chair of Thailand's Thonburi Healthcare Group said on Wednesday that a deal to import 20 million doses of the Pfizer-BioNTech COVID-19 vaccine was unlikely to happen, despite his earlier claims that a deal was close.
Boon did not say with which importer his group had been working. THG shares fell 8.13 per cent on Wednesday along a benchmark decline of 0.35 per cent. Thailand has since late April been faced with a surge in COVID-19 infections, driven by the highly contagious Delta variant of the coronavirus.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Thai central bank expected to hold rate at record low amid COVID-19 surge - Reuters pollThailand's central bank is expected to keep its key interest rate at a record low 0.50per cent on Wednesday, as the Southeast Asian country ...
Read more »
Pfizer and Moderna hiked their COVID-19 vaccine prices in the EU after AstraZeneca lost popularity there, report saysThe reported new contracts come as experts mull booster shots to combat the fast-spreading Delta coronavirus variant.
Read more »
A year after taboo on Thai king broken, 103 face jail for royal insultIn the year since making an unprecedented, taboo-breaking speech openly calling for discussion on the role of Thailand's powerful king, human ...
Read more »
Thai export group says factory outbreaks may cut August to December exports by US$9bBANGKOK: Thailand's key exports could decrease by as much as 300 billion baht (US$9 billion) in the remaining months of the year if the spread of ...
Read more »
Combining AstraZeneca and mRNA COVID-19 vaccines is effective -Danish studyCombining AstraZeneca's COVID-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna's jab provides 'good protection', Denmark's State Serum Institute said on Monday. A growing number of countries are looking at switching to different COVID-19 vaccines for second doses, a measure particularly necessary in Denmark after health authorities discontinued inoculations with AstraZeneca's vaccine in April over rare side-effect concerns.
Read more »